Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of plasmodium vivax to infect mosquitoes

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 6618-6623

  Hisaeda, Hajime ^a,b   Stowers, Anthony W ^a   Tsuboi, Takafumi ^c   Collins, William E ^d   Sattabongkot, Jetsumon S ^e   Suwanabun, Natavadee ^e   Torii, Motomi ^c   Kaslow, David C ^a,f  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MALARIA VACCINE; PROTEIN PVS25; PROTEIN PVS28; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGENICITY; MALARIA; MOSQUITO; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; VACCINATION; YEAST;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; CLONING, MOLECULAR; CULICIDAE; IMMUNE SERA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PAN TROGLODYTES; PLASMODIUM VIVAX; RECOMBINANT PROTEINS;

EID: 0034445516     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.6618-6623.2000     Document Type: Article

References (34)

1. Barr, P. J., K. M. Green, H. L. Gibson, I. C. Bathurst, I. A. Quakyi, and D. C. Kaslow. 1991. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J. Exp. Med. 174:1203-1208.
2. Duffy, P. E., and D. C. Kaslow. 1997. A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Infect. Immun. 65:1109-1113.
3. Duffy, P. E., P. Pimenta, and D. C. Kaslow. 1993 Pgs28 belongs to a family of epidermal growth factor-like antigens thai are targets of malaria transmission-blocking antibodies. J. Exp. Med. 177:505-510.
4. Engers, H. D., and T. Godal. 1998. Malaria vaccine development: current status. Parasitol. Today 14:56-64.
5. Fried, M., R. W. Gwadz, and D. C. Kaslow. 1994. Identification of two cysteine-rich, lipophilic proteins on the surface of Plasmodium knowlesi ookinetes: Pks20 and Pks24. Exp. Parasitol. 78:326-330.
6. Good, M. F., D. C. Kaslow, and L. H. Miller. 1998. Pathways and strategy for developing a malaria blood-stage vaccine. Annu. Rev. Immunol. 16:57-87.
7. Gozar, M. M. G., V. L. Price, and D. C. Kaslow. 1998. Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice. Infect. Immun. 60:59-64.
8. Hafalla, J. C. R., M. L. O. Santiago, M. C. J. Pasay, B. L. Ramirez, M. M. G. Gozar, A. Saul, and D. C. Kaslow. 1997. Minimal variation in the Pfs28 ookinete antigen from Philippine field isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 87:97-99.
9. Harinasuta, T., P. Suntharasamai, and C. Viravan. 1965. Chloroquine-resistant falciparum malaria in Thailand. Lancet 2:657-660.
10. Hoffman, S. L., W. O. Rogers, D. J. Carucci, and J. C. Venter. 1998. From genomics to vaccines: malaria as model system. Nat. Med. 4:1351-1353.
11. Kaslow, D. C. 1994. Progress towards transmission-blocking vaccine, p. 209-244. In M. F. Good and A. J. Saul (ed.), Molecular immunological considerations in malaria vaccine. CRC Press, London, England.
12. Kaslow, D. C., I. A. Quankyi, C. Syin, M. B. Raum, D. B. Keister, J. E. Coligan, T. F. McCutchan, and L. H. Miller. 1988. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 333:74-76.
13. Kaslow, D. C., C. Syin, T. F. McCutchan, and L. H. Miller. 1989. Comparison of the primary structure of the 25 kDa ookinete surface antigens of Plasmodium falciparum and Plasmodium gallinaceum reveal six conserved regions. Mol. Biochem. Parasitol. 33:283-287.
14. Kaslow, D. C., and J. Shiloach. 1994. Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose. Bio Technology 12: 494-499.
15. Kaslow, D. C., I. A. Quakyi, and D. B. Keister. 1989. Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum. Mol. Biochem. Parasitol. 32:101-103.
16. Kaslow, D. C., I. C. Bathurst, T. Lensen, T. Ponnuduraoi, P. J. Barr, and D. B. Keister. 1994. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. Infect. Immun. 62:5576-5580.
17. Kocken, C. H., J. Jansen, A. M. Kaan, P. J. Beckers, T. Ponnudurai, D. C. Kaslow, R. N. Konings, and J. G. Schoenmakers. 1993. Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol. Biochem. Parasitol. 61:59-68.
18. Kumar, N., and R. Carter. 1985. Biosynthesis of two-stage-specific membrane proteins during transformation of Plasmodium gallinaceum zygotes into ookinete. Mol. Biochem. Parasitol. 14:127-139.
19. McDonald, N. Q., and W. A. Hendrickson. 1993. A structural superfamily of growth factors containing a cystine knot motif. Cell 73:421-424.
20. Mendis, K. N., Y. D. Muneshinghe, Y. N. de Silva, I. Keragalla, and R. Carter. 1987. Malaria transmission-blocking immunity induced by natural infection of Plasmodium vivax in humans. Infect. Immun. 55:369-372.
21. Premawansa, S., J. S. Peiris, K. L. Perera, G. Ariyaratne, R. Carter, and K. N. Mendis. 1990. Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates. J. Immunol. 144:4376-4383.
22. Rieckmann, K. H., D. R. Davis, and C. D. Hutton. 1989. Plasmodium vivax resistance to chloroquine? Lancet 2:1183-1184.
23. Roberts, D. R., and R. G. Andre. 1994. Insecticide resistance issues in vectorbore disease control. Am. J. Trop. Med. Hyg. 50:21-34.
24. Shahabuddine, M., S. Cociancich, and H. Zieler. The search for novel malaria transmission-blocking targets in the mosquito midgut. Parasitol. Today 14:493-497.
25. Sharma, B. K., K. K. Talwar, V. Bhatnagar, L. Kumar, N. K. Ganguly, and R. C. Mahajan. 1979. Recurrent anaphylaxis due to Plasmodium vivax infection. Lancet 1:1340-1341.
26. Snewin, V. A., S. Premawansa, G. M. G. Kapilananda, L. Ratnayaka, P. V. Udagama, D. M. Mattei, E. Khouri, G. DelGiudice, J. S. M. Peiris, K. N. Mendis, and P. H. David. 1995. Transmission blocking immunity in Plasmodium vivax malaria: antibodies raised against a peptide block parasite development in the mosquito vector. J. Exp. Med. 181:357-362.
27. Stowers, A. W., D. B. Keister, O. Muratova, and D. C. Kaslow. 2000. A region of Plasmodium falciparum antigen Pvs25 that is the target of highly potent transmission-blocking antibodies. Infect. Immun. 68:5530-5538.
28. Sullivan, J. S., C. L. Morris, H. M. McClure, E. Strobert, B. B. Richardson, G. G. Galland, I. F. Goldman, and W. E. Collins. 1996. Plasmodium vivax infections in chimpanzees for sporozoite challenge studies in monkeys. Am. J. Trop. Med. Hyg. 55:344-349.
29. Tsuboi, T., Y.-M. Cao, D. C. Kaslow, K. Shiwaku, and M. Torii. 1997. Primary structure of a novel ookinete surface protein from Plasmodium berghei. Mol. Biochem. Parasitol. 85:131-134.
30. Tsuboi, T., D. C. Kaslow, Y.-M. Cao, K. Shiwaku, and M. Torii. 1997. Comparison of Plasmodium yoelii ookinete surface antigens with human and avian malaria parasite homologues reveals two highly conserved regions. Mol. Biochem. Parasitol. 87:107-111.
31. Tsuboi, T., D. C. Kaslow, M. M. G. Gozar, M. Tachibana, Y.-M. Cao, and M. Torii. 1998. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Mol. Med. 4:772-782.
32. Tsuboi, T., Y.-M. Cao, Y. Hitsumoto, T. Yanagi, H. Kanbara, and M. Torii. 1997. Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity. Infect. Immun. 65:2260-2264.
33. Williamson, K. C., M. D. Criscio, and D. C. Kaslow. 1993. Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230. Mol. Biochem. Parasitol. 58:355-358.
34. World Health Organization. 1997. World malaria situation in 1994. Wkly. Epidemiol. Rec. 72:285-292.